Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 1/20 | 0.47 |
| ▸ | CCND1 | P24385 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 6/20 | 0.44 |
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MPO | P05164 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11437846 | 0.83 | HSPA5 (0.59) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL8577793 | 0.80 | HSPA5 (0.46) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL24397717 | 0.80 | HSPA5 (0.46) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL29956337 | 0.79 | HSPA5 (0.54) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL1008770 | 0.79 | HSPA5 (0.54) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL2787053 | 0.78 | HSPA5 (0.45) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL5148439 | 0.77 | HSPA5 (0.43) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL1349024 | 0.77 | HSPA5 (0.52) | TSHRCYP2D6HIF1AHSPA5TAAR1 | |
| SCHEMBL30753809 | 0.76 | TAAR1 (0.45) | TSHRCYP2D6TAAR1HSD17B10IDO1 | |
| SCHEMBL13824528 | 0.76 | TAAR1 (0.45) | CYP2D6TAAR1IDO1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104508116-A | Pesticidal flavobacterium strains and bioactive compositions, metabolites and uses | MARRONE BIO INNOVATIONS INC | 2015-04-08 | — | — | CN | claimed |
| WO-2024150793-A1 | POLYCRYSTALLINE FORM OF BIPHENOL DIGLYCIDYL ETHER, AND RESIN COMPOSITION CONTAINING SAID POLYCRYSTALLINE FORM AND CURED PRODUCT THEREOF | 三菱ケミカル株式会社 | 2024-07-18 | — | — | WO | disclosed |
| US-20240217907-A1 | PHENOL MIXTURE, EPOXY RESIN, EPOXY RESIN COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| WO-2024135713-A1 | EPOXY RESIN, PRODUCTION METHOD FOR SAME, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | 三菱ケミカル株式会社 | 2024-06-27 | — | — | WO | disclosed |
| EP-4375309-A1 | PHENOL MIXTURE, EPOXY RESIN, EPOXY RESIN COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | Mitsubishi Chemical Corporation (JP) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024070871-A1 | METHOD FOR PRODUCING BISPHENOL, METHOD FOR PRODUCING EPOXY RESIN, METHOD FOR PRODUCING EPOXY RESIN CURED PRODUCT, AND BISPHENOL COMPOSITION | 三菱ケミカル株式会社 | 2024-04-04 | — | — | WO | disclosed |
| CN-117751164-A | Phenol mixture, epoxy resin composition, cured product, and electric/electronic component | 三菱化学株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-111527120-B | Epoxy resin composition, cured product, and electrical/electronic component | 三菱化学株式会社 | 2023-11-17 | — | — | CN | disclosed |
| WO-2023002902-A1 | PHENOL MIXTURE, EPOXY RESIN, EPOXY RESIN COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | 三菱ケミカル株式会社 | 2023-01-26 | — | — | WO | disclosed |
| CN-115244101-A | Epoxy resin composition, cured product, and electrical/electronic component | 三菱化学株式会社 | 2022-10-25 | — | — | CN | disclosed |
| CN-107090414-A | Desinsection flavobacterium strain | 马罗内生物创新公司 | 2017-08-25 | — | — | CN | disclosed |
| CN-104508116-B | Pesticidal flavobacterium strains and bioactive compositions, metabolites and uses | 马罗内生物创新公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-104508116-A | Pesticidal flavobacterium strains and bioactive compositions, metabolites and uses | MARRONE BIO INNOVATIONS INC | 2015-04-08 | — | — | CN | disclosed |
| EP-1858975-B1 | MODIFIED NOVOLAK RESIN FOR USE AS TACKIFIER | SCHENECTADY INT INC (US) | 2014-06-04 | — | — | EP | disclosed |
| US-7772345-B2 | Modified novolak resin for use as tackifier | SI GROUP, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| EP-1858975-A4 | MODIFIED NOVOLAK RESIN FOR USE AS TACKIFIER | SCHENECTADY INT INC (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-1858975-A2 | MODIFIED NOVOLAK RESIN FOR USE AS TACKIFIER | SCHENECTADY INTERNATIONAL, INC. (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006093676-A2 | MODIFIED NOVOLAK RESIN FOR USE AS TACKIFIER | SI GROUP, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20060199924-A1 | Modified novolak resin for use as tackifier | SCHENECTADY INTERNATIONAL, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| US-4167540-A | BUTADIENE-STYRENE COPOLYMER | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217907-A1 | PHENOL MIXTURE, EPOXY RESIN, EPOXY RESIN COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | ESR1, EED, PTGES | CDK4 1921/4885CCND1 2572/4885TSHR 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.